InvestorsHub Logo
Followers 87
Posts 7084
Boards Moderated 2
Alias Born 02/24/2012

Re: fouraces post# 70203

Wednesday, 04/17/2013 10:52:50 AM

Wednesday, April 17, 2013 10:52:50 AM

Post# of 130516

Given an estimated ~390 million share count, that equates to a target price of $0.24 per share. I expect the value of Amarantus to rise as investors become more familiar with LymPro and the company begins to generate the necessary data for a CLIA filing.


The content of my post should never be taken seriously or considered when making investment decisions.